Latest filing published 09 Jan 2023 for Apellis Pharmaceuticals, Inc., €115k.
Filing timeline
BuySaleInsider track record
Federico Grossi: trading record in brief
Federico Grossi, listed as senior executive, appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 11 April 2018 to 5 January 2023, the count stands at 66 filings.
Sales make up the whole of the open-market record (41 sales, €1.9M). Besides market trades, the filings include 7 share grants and 16 option exercises. Since January 2023: no purchases and 1 sale on the market.
The newest entry dates from 9 January 2023: an open-market sale of €115k, in Apellis Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Federico Grossi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,500 shares@ US$48.7913.6% of flowCommon StockSEC:0001127602-23-001182:0
- 2,500 shares@ US$49.9314.2% of flowCommon StockSEC:0000899243-22-037437:0
- 2,500 shares@ US$60.8318.2% of flowCommon StockSEC:0000899243-22-034914:0
- 2,500 shares@ US$66.6920.0% of flowCommon StockSEC:0001127602-22-023728:0
- 2,500 shares@ US$60.3017.9% of flowCommon StockSEC:0001127602-22-022000:0
- 2,500 shares@ US$55.9916.1% of flowCommon StockSEC:0001127602-22-020150:0
- 2,500 shares@ US$41.7816.6% of flowCommon StockSEC:0001127602-22-016470:0
- 2,500 shares@ US$43.564.7% of flowCommon StockSEC:0001127602-22-013110:1
- 1,875 shares0Common StockSEC:0001127602-22-013110:0
- 375 shares@ US$39.570.6% of flowCommon StockSEC:0001127602-22-009795:1
- 7,000 shares@ US$4.314.7% of flowCommon StockSEC:0001127602-22-009795:0
- 375 shares@ US$43.532.5% of flowCommon StockSEC:0001127602-22-007825:0
- 4,100 shares@ US$4.312.6% of flowCommon StockSEC:0001127602-22-006574:0
- 375 shares@ US$45.432.5% of flowCommon StockSEC:0001127602-22-005299:0
- 3,600 shares@ US$4.312.3% of flowCommon StockSEC:0001127602-22-005042:0
- 705 shares@ US$47.124.9% of flowCommon StockSEC:0001127602-22-004810:0
- 375 shares@ US$40.582.3% of flowCommon StockSEC:0001127602-22-002980:0
- 650 shares@ US$38.593.8% of flowCommon StockSEC:0001127602-22-002813:0
- 26,051 shares0Common StockSEC:0001127602-22-002064:0
- 375 shares@ US$40.560.6% of flowCommon StockSEC:0000899243-22-002519:1
- 3,400 shares@ US$4.312.2% of flowCommon StockSEC:0000899243-22-002519:0
- 1,500 shares@ US$4.310.3% of flowCommon StockSEC:0001127602-22-001531:1
- 3,661 shares@ US$3.762.0% of flowCommon StockSEC:0001127602-22-001531:0
- 375 shares@ US$47.312.6% of flowCommon StockSEC:0001127602-22-000422:0
- 375 shares@ US$42.882.4% of flowCommon StockSEC:0001127602-21-031428:0
25 of 66 declarations
